V
Vinojini Vivekanandam
Researcher at University College London Hospitals NHS Foundation Trust
Publications - 6
Citations - 863
Vinojini Vivekanandam is an academic researcher from University College London Hospitals NHS Foundation Trust. The author has contributed to research in topics: Channelopathy & Medicine. The author has an hindex of 2, co-authored 3 publications receiving 494 citations. Previous affiliations of Vinojini Vivekanandam include UCL Institute of Neurology.
Papers
More filters
Journal ArticleDOI
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.
Ross W. Paterson,Ross W. Paterson,Rachel Brown,Laura A Benjamin,Laura A Benjamin,Ross Nortley,Ross Nortley,Sarah Wiethoff,Sarah Wiethoff,Tehmina Bharucha,Tehmina Bharucha,Tehmina Bharucha,Dipa L Jayaseelan,Dipa L Jayaseelan,Guru Kumar,Rhian E Raftopoulos,Laura Zambreanu,Laura Zambreanu,Vinojini Vivekanandam,Anthony Khoo,Ruth Geraldes,Ruth Geraldes,Krishna Chinthapalli,Krishna Chinthapalli,Elena Boyd,Hatice Tuzlali,Gary Price,Gerry Christofi,Jasper M. Morrow,Jasper M. Morrow,Patricia McNamara,Benjamin C Mcloughlin,Soon Tjin Lim,Puja Mehta,Viva Levee,Stephen Keddie,Wisdom Yong,S Anand Trip,S Anand Trip,Alexander J.M. Foulkes,Alexander J.M. Foulkes,Gary Hotton,Thomas D. Miller,Alex Everitt,Christopher Carswell,Nicholas W. S. Davies,Michael Yoong,David Attwell,Jemeen Sreedharan,Eli Silber,Jonathan M. Schott,Arvind Chandratheva,Richard J. Perry,Robert Simister,Anna M. Checkley,Nicky Longley,Simon F. Farmer,Francesco Carletti,Catherine F Houlihan,Maria Thom,Michael P. Lunn,Jennifer Spillane,Jennifer Spillane,Robin Howard,Robin Howard,Angela Vincent,Angela Vincent,David J. Werring,Chandrashekar Hoskote,Hans Rolf Jäger,Hans Rolf Jäger,Hadi Manji,Hadi Manji,Michael S. Zandi,Michael S. Zandi +74 more
TL;DR: A case series of 43 patients with neurological complications of SARS-CoV-2 infection includes encephalopathies, encephalitis, acute disseminated encephalomyelitis with haemorrhagic change, transverse myelitis, ischaemic stroke, and Guillain-Barré syndrome.
Journal ArticleDOI
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
Laura A Benjamin,Ross W. Paterson,Rachel Moll,Charis Pericleous,Rachel Brown,Rachel Brown,Rachel Brown,Puja Mehta,Puja Mehta,Dilan Athauda,Dilan Athauda,Oliver J. Ziff,Oliver J. Ziff,Oliver J. Ziff,Judith Heaney,Anna M. Checkley,Catherine F Houlihan,Catherine F Houlihan,Michael Chou,Amanda J. Heslegrave,Amanda J. Heslegrave,Arvind Chandratheva,Arvind Chandratheva,Benedict D Michael,Benedict D Michael,Benedict D Michael,Kaj Blennow,Vinojini Vivekanandam,Vinojini Vivekanandam,Alexander Foulkes,Catherine J. Mummery,Catherine J. Mummery,Michael P. Lunn,Stephen Keddie,Moira J. Spyer,Thomas A. J. McKinnon,Melanie Hart,Francesco Carletti,Hans Rolf Jäger,Hans Rolf Jäger,Hadi Manji,Michael S. Zandi,Michael S. Zandi,David J. Werring,David J. Werring,Eleni Nastouli,Robert Simister,Robert Simister,Tom Solomon,Tom Solomon,Tom Solomon,Henrik Zetterberg,Henrik Zetterberg,Jonathan M. Schott,Jonathan M. Schott,Hannah Cohen,Maria Efthymiou +56 more
TL;DR: In this article, the authors evaluated nine antiphospholipid antibodies: anticardiolipin antibodies [aCL] IgA, IgM, IgG; anti-beta-2 glycoprotein-1 [aβ2GPI]IgA,IgM, IgG; and anti-phosphatidylserine/prothrombin [aPS/PT] IgG.
Journal ArticleDOI
Reply: Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe?
Ross W. Paterson,Ross W. Paterson,Rachel Brown,Vinojini Vivekanandam,Alexander J.M. Foulkes,Alexander J.M. Foulkes,Maria Thom,Sarah Wiethoff,Sarah Wiethoff,Laura A Benjamin,Laura A Benjamin,Gerry Christofi,Patricia McNamara,Jasper M. Morrow,Jasper M. Morrow,Thomas D. Miller,Ross Nortley,Ross Nortley,Ruth Geraldes,Ruth Geraldes,David Attwell,Guru Kumar,Alex Everitt,Nicholas W S Davies,S Anand Trip,S Anand Trip,Eli Silber,Robin Howard,Robin Howard,Richard J. Perry,David J. Werring,Anna M. Checkley,Nicky Longley,Jennifer Spillane,Jennifer Spillane,Michael P. Lunn,Chandrashekar Hoskote,Hans Rolf Jäger,Hans Rolf Jäger,Hadi Manji,Hadi Manji,Michael S. Zandi,Michael S. Zandi +42 more
Journal ArticleDOI
COVID‐19 infection and vaccination in patients with skeletal muscle channelopathies
TL;DR: The impact of CO VID‐19 and COVID‐19 vaccination on skeletal muscle channelopathies is studied to study the consequences for patients with neuromuscular disorders.
Journal ArticleDOI
Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing
Vinojini Vivekanandam,Rawan Jaibaji,Richa Sud,Rebecca Ellmers,I Skorupinska,Louis M. Germaine,N. James,S. Holmes,Roope Manniko,Dipa Jaysaeelan,Michael G. Hanna +10 more
TL;DR: In this paper , the authors provided an up-to-date and accurate minimum point prevalence of genetically defined skeletal muscle channelopathies which is important for understanding the population impact, planning for treatment needs and future clinical trials.